Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   A Phase 2 Open-Label, Randomized Study of PARP Inhibition (Olaparib) Either Alone or in Combination With Anti-PD-L1 Therapy (Atezolizumab; MPDL3280A) in Homologous DNA Repair (HDR) Deficient, Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Disease/Condition   Breast Cancer,Oncology (Medical/Hematologic),Neoplasms
Description  

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Jesus Anampa Mesias, MD
Contact Name   Amanda Erakky
Contact Email   aerakky@montefiore.org
Protocol Number   2017-8327
Inclusion/Notes   This Information was obtained from ClinicalTrials.gov
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Medical and Hematologic Oncology - Breast
Adult, Pediatric, Both   Adult